MedPath

Effect of Myofascial Release with Pain Neuroscience Education on Central Sensitizatio

Not Applicable
Completed
Conditions
Diseases of the musculoskeletal system and connective tissue
Registration Number
KCT0006455
Lead Sponsor
Sahmyook University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
28
Inclusion Criteria

Adult men and women aged 20 or older and under 75 who have been diagnosed with non-specific low back pain and whose symptoms last more than 12 weeks
- Those with 28 points or more in the central sensitization inventory
- Those who have experienced back pain of 3 or higher on the numeric pain rating scale within the past 7 days

Exclusion Criteria

- Those who have had neck or back surgery within 3 years
- Those diagnosed with mental illness
- Those with rheumatic disease, neurological disease, heart disease, respiratory disease, metabolic disease, endocrine disease
- Those with chronic pain syndromes such as fibromyalgia or chronic fatigue syndrome
- Those with loss of skin sensation
- Those with skin inflammation or swelling on the back
- Those who have taken painkillers for more than 10 days a month or have used oral/systemic steroids

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umeric Pain Rating Scale;Central Sensitization Inventory
Secondary Outcome Measures
NameTimeMethod
Pain Catastrophizing Scale;Tampa Scale of Kinesiophobia;Pressure Pain Threshold;The Roland-Morris Disability Questionnaire
© Copyright 2025. All Rights Reserved by MedPath